Citations for
1DPYSL5, NDDCCA
Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities
Jeanne M, Demory H, Moutal A, Vuillaume ML, Blesson S, Thépault RA, Marouillat S, Halewa J, Maas SM, Motazacker MM, Mancini GMS, van Slegtenhorst MA, Andreou A, Cox H, Vogt J, Laufman J, Kostandyan N, Babikyan D, Hancarova M, Bendova S, Sedlacek Z, Aldinger KA, Sherr EH, Argilli E, England EM, Audebert-Bellanger S, Bonneau D, Colin E, Denommé-Pichon AS, Gilbert-Dussardier B, Isidor B, Küry S, Odent S, Redon R, Khanna R, Dobyns WB, Bézieau S, Honnorat J, Lohkamp B, Toutain A, Laumonnier F.
Am J Hum Genet. May 6;108(5):951-961. doi: 10.1016/j.ajhg.2021.04.004. Epub 2021 Apr 23. 2021
2DPYSL5, SOX5
Transcriptional regulation of CRMP5 controls neurite outgrowth through Sox5.
Naudet N, Moutal A, Vu HN, Chounlamountri N, Watrin C, Cavagna S, Malleval C, Benetollo C, Bardel C, Dronne MA, Honnorat J, Meissirel C, Besançon R.
Cell Mol Life Sci 75(1):67-79. doi: 10.1007/s00018-017-2634-6. Epub 2017 Sep 1. 2018
3DPYSL5
DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.
Wang L, Liu W, Tang H, Xie X, Zou C, Wang Y, Gao Z, Yin J.
Cancer Med 6(5):982-993. doi: 10.1002/cam4.1009. Epub 2017 Apr 4. 2017
4DPYSL5
CRMP‑5 interacts with actin to regulate neurite outgrowth.
Gong X, Tan M, Gao Y, Chen K, Guo G.
Mol Med Rep 13(2):1179-85. doi: 10.3892/mmr.2015.4662. Epub 2015 Dec 9. 2016
5DPYSL5
CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.
Moutal A, Honnorat J, Massoma P, Désormeaux P, Bertrand C, Malleval C, Watrin C, Chounlamountri N, Mayeur ME, Besançon R, Naudet N, Magadoux L, Khanna R, Ducray F, Meyronet D, Thomasset N.
Cancer Res 75(17):3519-28. doi: 10.1158/0008-5472.CAN-14-0631. Epub 2015 Jun 29. 2015
6DPYSL5
Collapsin response mediator protein 5 (CRMP5) induces mitophagy, thereby regulating mitochondrion numbers in dendrites.
Brot S, Auger C, Bentata R, Rogemond V, Ménigoz S, Chounlamountri N, Girard-Egrot A, Honnorat J, Moradi-Améli M.
J Biol Chem 289(4):2261-76. doi: 10.1074/jbc.M113.490862. Epub 2013 Dec 9. 2014
7DPYSL5
Insights into the oligomerization of CRMPs: crystal structure of human collapsin response mediator protein 5.
Ponnusamy R, Lohkamp B.
J Neurochem 125(6):855-68. doi: 10.1111/jnc.12188. Epub 2013 Mar 5. 2013
8DPYSL5
Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation.
Brot S, Malleval C, Benetollo C, Auger C, Meyronet D, Rogemond V, Honnorat J, Moradi-Améli M.
Exp Cell Res 319(5):588-99. doi: 10.1016/j.yexcr.2012.12.011. Epub 2013 Jan 5. 2013
9DPYSL5
The collapsin response mediator protein 5 onconeural protein is expressed in Schwann cells under axonal signals and regulates axon-Schwann cell interactions.
Camdessanché JP, Ferraud K, Boutahar N, Lassablière F, Mutter M, Touret M, Kolattukudy P, Honnorat J, Antoine JC.
J Neuropathol Exp Neurol 71(4):298-311. doi: 10.1097/NEN.0b013e31824d1df2. 2012
10DPYSL5
CRMP5 (collapsin response mediator protein 5) regulates dendritic development and synaptic plasticity in the cerebellar Purkinje cells.
Yamashita N, Mosinger B, Roy A, Miyazaki M, Ugajin K, Nakamura F, Sasaki Y, Yamaguchi K, Kolattukudy P, Goshima Y.
J Neurosci 31(5):1773-9. 2011
11DPYSL2, DPYSL5
CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2.
Brot S, Rogemond V, Perrot V, Chounlamountri N, Auger C, Honnorat J, Moradi-Améli M.
J Neurosci 30(32):10639-54. 2010
12DPYSL5
Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.
Meyronet D, Massoma P, Thivolet F, Chalabreysse L, Rogemond V, Schlama A, Honnorat J, Thomasset N.
Am J Surg Pathol 32(11):1699-708. 2008
13DPYSL5
Localization of CRMP5 mRNA by in situ hybridisation during development of the mouse forebrain.
McLaughlin D, Vidaki M, Karagogeos D.
Neurosci Lett 432(2):117-20. Epub 2007 Dec 15. 2008
14DPYSL2, DPYSL5
Expression of collapsin response mediator proteins 1, 2 and 5 is differentially regulated in newly generated and mature neurons of the adult olfactory system.
Veyrac A, Giannetti N, Charrier E, Reymond-Marron I, Aguera M, Rogemond V, Honnorat J, Jourdan F.
Eur J Neurosci 21(10):2635-48. 2005
15DPYSL5
Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.
Cross SA, Salomao DR, Parisi JE, Kryzer TJ, Bradley EA, Mines JA, Lam BL, Lennon VA.
Ann Neurol 54(1):38-50. Review. 2003
16DPYSL2, DPYSL5, SEMA3A
Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes.
Ricard D, Rogemond V, Charrier E, Aguera M, Bagnard D, Belin MF, Thomasset N, Honnorat J.
J Neurosci 21(18):7203-14. 2001
17DPYSL5
CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.
Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA.
Ann Neurol 49(2):146-54. 2001
18DPYSL5
Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family.
Fukada M, Watakabe I, Yuasa-Kawada J, Kawachi H, Kuroiwa A, Matsuda Y, Noda M.
J Biol Chem 275(48):37957-65. 2000
19DPYSL5
Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain.
Inatome R, Tsujimura T, Hitomi T, Mitsui N, Hermann P, Kuroda S, Yamamura H, Yanagi S.
J Biol Chem 275(35):27291-302. 2000
20DPYSL4, DPYSL5
Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain.
Inatome R, Tsujimura T, Hitomi T, Mitsui N, Hermann P, Kuroda S, Yamamura H, Yanagi S.
J Biol Chem 275(35):27291-302.PMID: 10851247 2000
21CRMP1, DPYD, DPYS, DPYSL2, DPYSL3, DPYSL4, DPYSL5
A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution.
Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M, Nonaka M.
Gene 180(1-2):157-63. 1996